Astellas Pharma, Inc. (ALPMF)
12.90
+0.68
(+5.52%)
USD |
OTCM |
Dec 09, 16:00
Astellas Pharma Profit Margin (Quarterly): 15.11% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | -1.05% |
| Nxera Pharma Co., Ltd. | -24.76% |
| PeptiDream Inc. | -25.38% |
| Stemcell Holdings, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 8.36% |
| Return on Assets | 3.75% |
| Return on Invested Capital | 5.20% |
| Gross Profit Margin (Quarterly) | 73.63% |
| Operating Margin (Quarterly) | 20.53% |
| Return on Net Operating Assets | 4.53% |